These four cases were selected as part of this case series as they highlight several benefits of SIP use, including the ability to potentially improve glycemic control, adherence, and/or self-engagement in diabetes management in patients with poorly controlled T1DM managed by MDIs and not insulin pumps. This evidence concerns the gene INS and type 1 diabetes mellitus.